Study of the stability of 26 cytostatic drugs and metabolites in wastewater under different conditions

Science of the Total Environment

Volumn 482-483, Issue 1, 2014, Pages 389-398

  Negreira, Noelia ^a   López de Alda, Miren ^a   Barceló, Damià ^a,b  

^a INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

^b CATALAN INSTITUTE FOR WATER RESEARCH ICRA   (Spain)

Author keywords

Cytostatics; Electrospray; Liquid chromatography mass spectrometry; Stability; Storage; Wastewater samples

Indexed keywords

BIOMOLECULES; CONVERGENCE OF NUMERICAL METHODS; ENERGY STORAGE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; STABILITY;

CYTOSTATICS; ELECTROSPRAYS; HIGH TEMPERATURE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; PARENT COMPOUNDS; TARGET COMPOUND; UNSTABLE COMPOUNDS; WASTEWATER SAMPLES;

DIGITAL STORAGE;

AMIDE; AZATHIOPRINE; CHLORAMBUCIL; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DOCETAXEL; ERLOTINIB; ETOPOSIDE; IFOSFAMIDE; IMATINIB; NAVELBINE; OXALIPLATIN; TAMOXIFEN; TEMOZOLOMIDE;

DRUG; EXPERIMENTAL DESIGN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; WASTEWATER;

ACIDIFICATION; ARTICLE; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; EXPERIMENTAL DESIGN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PH; PRIORITY JOURNAL; PROCESS OPTIMIZATION; STANDARDIZATION; TEMPERATURE; TIME; WASTE WATER; WASTE WATER MANAGEMENT;

CYTOSTATICS; ELECTROSPRAY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; STABILITY; STORAGE; WASTEWATER SAMPLES;

CHROMATOGRAPHY, LIQUID; CYTOSTATIC AGENTS; HYDROGEN-ION CONCENTRATION; MASS SPECTROMETRY; MODELS, CHEMICAL; TANDEM MASS SPECTROMETRY; TEMPERATURE; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84896449399     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.02.131     Document Type: Article

References (27)

1. Baker D.R., Kasprzyk-Hordern B. Critical evaluation of methodology commonly used in sample collection, storage and preparation for the analysis of pharmaceuticals and illicit drugs in surface water and wastewater by solid phase extraction and liquid chromatography-mass spectrometry. J Chromatogr A 2011, 1218:8036-8059.
2. Bende G., Kollipara S., Kolachina V., Saha R. Development and validation of a stability indicating RP-LC method for determination of imatinib mesylate. Chromatographia 2007, 66:859-866.
3. Bouraoui S., Brahem A., Tabka F., Mrizek N., Saad A., Elghezal H. Assessment of chromosomal aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from Tunisian nurses handling cytotoxic drugs. Environ Toxicol Pharmacol 2011, 31:250-257.
4. Ferrando-Climent L., Rodriguez-Mozaz S., Barcelo D. Development of a UPLC-MS/MS method for the determination of ten anticancer drugs in hospital and urban wastewaters, and its application for the screening of human metabolites assisted by information-dependent acquisition tool (IDA) in sewage samples. Anal Bioanal Chem 2013, 405:5937-5952.
5. Gomez-Canela C., Cortes-Francisco N., Oliva X., Pujol C., Ventura F., Lacorte S., et al. Occurrence of cyclophosphamide and epirubicin in wastewaters by direct injection analysis-liquid chromatography-high-resolution mass spectrometry. Environ Sci Pollut Res Int 2012, 19:3210-3218.
6. International Agency on the Research on Cancer I Agents classified by the IARC monographs 2012, vol. 1-105. [http://monographs.iarc.fr/ENG/Classification/ update 28 june].
7. Johnson A.C., Jürgens M.D., Williams R.J., Kümmerer K., Kortenkamp A., Sumpter J.P. Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. J Hydrol 2008, 348:167-175.
8. Kiffmeyer T., Götze H.-J., Jursch M., Lüders U. Trace enrichment, chromatographic separation and biodegradation of cytostatic compounds in surface water. Fresenius J Anal Chem 1998, 361:185-191.
9. Kosjek T., Heath E. Occurrence, fate and determination of cytostatic pharmaceuticals in the environment. TrAC Trends Anal Chem 2011, 30:1065-1087.
10. Kosjek T., Perko S., Žigon D., Heath E. Fluorouracil in the environment: analysis, occurrence, degradation and transformation. J Chromatogr A 2013, 1290:62-72.
11. Kovalova L., McArdell C.S., Hollender J. Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry. J Chromatogr A 2009, 1216:1100-1108.
12. Kümmerer K., Al-Ahmad A. Biodegradability of the anti-tumour agents 5-fluorouracil, cytarabine, and gemcitabine: impact of the chemical structure and synergistic toxicity with hospital effluent. Acta Hydrochim Hydrobiol 1997, 25:166-172.
13. Lenz K., Koellensperger G., Hann S., Weissenbacher N., Mahnik S.N., Fuerhacker M. Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents. Chemosphere 2007, 69:1765-1774.
14. Mahnik S.N., Rizovski B., Fuerhacker M., Mader R.M. Determination of 5-fluorouracil in hospital effluents. Anal Bioanal Chem 2004, 380:31-35.
15. Mahnik S.N., Lenz K., Weissenbacher N., Mader R.M., Fuerhacker M. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere 2007, 66:30-37.
16. Martin J., Camacho-Munoz D., Santos J.L., Aparicio I., Alonso E. Simultaneous determination of a selected group of cytostatic drugs in water using high-performance liquid chromatography-triple-quadrupole mass spectrometry. J Sep Sci 2011, 34:3166-3177.
17. Mullot J.U., Karolak S., Fontova A., Huart B., Levi Y. Development and validation of a sensitive and selective method using GC/MS-MS for quantification of 5-fluorouracil in hospital wastewater. Anal Bioanal Chem 2009, 394:2203-2212.
18. Negreira N., López de Alda M., Barceló D. On-line solid phase extraction-liquid chromatography-tandem mass spectrometry for the determination of 17 cytostatics and metabolites in waste, surface and ground water samples. J Chromatogr A 2013, 1280:64-74.
19. Negreira N., Mastroianni N., López de Alda M., Barceló D. Multianalyte determination of 24 cytostatics and metabolites by liquid chromatography-electrospray-tandem mass spectrometry and study of their stability and optimum storage conditions in aqueous solution. Talanta 2013, 116:290-299.
20. Nussbaumer S., Bonnabry P., Veuthey J.L., Fleury-Souverain S. Analysis of anticancer drugs: a review. Talanta 2011, 85:2265-2289.
21. Smerhovsky Z., Landa K., Rössner P., Brabec M., Zudova Z., Hola N., et al. Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations. Environ Health Perspect 2001, 109:41-45.
22. Steger-Hartmann T., Kümmerer K., Hartmann A. Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicol Environ Saf 1997, 36:174-179.
23. Turci R., Sottani C., Spagnoli G., Minoia C. Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. J Chromatogr B 2003, 789:169-209.
24. Yin J., Shao B., Zhang J., Li K. A preliminary study on the occurrence of cytostatic drugs in hospital effluents in Beijing, China. Bull Environ Contam Toxicol 2010, 84:39-45.
25. Zhang J., Chang V.W., Giannis A., Wang J.Y. Removal of cytostatic drugs from aquatic environment: a review. Sci Total Environ 2013, 445-446:281-298.
26. Zounková R., Odráška P., Doležalová L., Hilscherová K., Maršálek B., Bláha L. Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals. Environ Toxicol Chem 2007, 26:2208-2214.
27. Zounkova R., Kovalova L., Blaha L., Dott W. Ecotoxicity and genotoxicity assessment of cytotoxic antineoplastic drugs and their metabolites. Chemosphere 2010, 81:253-260.